Role of genetically determined fetal hemostatic disorders in the development of severe forms of placental insufficiency
Objective. To study the specific features of development of genetically determined fetal hemostatic disorders and their role in the genesis of severe forms of placental insufficiency.Nesterova E.A., Putilova N.V., Tretyakova T.B., Pestryaeva L.A.
Subjects and methods. Seventy married couples and their newborns underwent clinical and laboratory examinations and constituted two groups: a study group (n = 50), in which their pregnancy was complicated by sub- or decompensated forms of placental insufficiency, and a control group (n = 20) without a compromised obstetric history, with current physiological pregnancy. The polymorphic variants of the genes involved in blood aggregation and folate metabolism were investigated by real-time polymerase chain reaction; the blood coagulation system was evaluated in women and babies.
Results. The women in the study group were found to have statistically significant differences in the frequency of polymorphic variants of the genes: PAI-1, ITGB3, F7, F13, and MTHFR; the men in this group had PAI-1, ITGA2 807; their newborn babies had PAI-1 and MTHFR. In addition, in the study group the women and babies were detected to have the clotting disorders indicating the activation of intravascular microcoagulation.
Conclusion. Clinically significant fetal thrombophilia makes a considerable contribution to the development of severe forms of placental insufficiency.
Keywords
Supplementary Materials
- Table 1. Comparative characteristics of hemostasis parameters in pregnant women оf the primary and control groups of study, (M ± m)
- Table 2. Comparative characteristics of hemostasis parameters in newborns of the primary and control groups, (M ± m)
- Picture. Polymorphisms of thrombophilia genes that have significantly significant differences in the frequency of occurrence in the study groups
References
1. Тезиков Ю.В., Липатов И.С., Агаркова И.А. Факторы риска декомпенсации плацентарной недостаточности. Казанский медицинский журнал. 2011; 92(3): 372-5. [Tezikov Yu.V., Lipatov I.S., Agarkova I.A. Risk factors of decompensation of placental insufficiency. Kazan Medical Journal. 2011; 92(3): 372-5. (in Russian)]
2. Филиппов О.С. Плацентарная недостаточность. М.: МЕДпресс-информ; 2009. 160с. [Filippov O.S. Placental insufficiency. Moscow: MEDpress-Inform; 2009. 160p. (in Russian)]
3. Krishna U., Bhalerao S. Placental insufficiency and fetal growth restriction. J. Obstet. Gynaecol. India. 2011; 61(5): 505-11.
4. Айламазян Э.К., Кулаков В.И., Радзинский В.Е., Савельева Г.М., ред. Акушерство. Национальное руководство. М.: ГЭОТАР-Медиа; 2013. 1200с. [Ailamazyan E.K., Kulakov V.I., Radzinsky V.E., Savelyeva G.M., ed. Obstetrics: National guideline. Moscow: GEOTAR-Media; 2013. 1200p. (in Russian)]
5. Сидельникова В.М., Сухих Г.Т. Актуальные проблемы невынашивания беременности. Руководство для практических врачей. М.: МИА; 2009. 536с. [Sidelnikov V.M., Sukhikh G.T. Actual problems of miscarriage. Guidance for practitioners. Moscow: MIA; 2009. 536p. (in Russian)]
6. Зарудская О.М., Чурносов М.И. Роль наследственной тромбофилии в развитии хронической фето-плацентарной недостаточности и синдрома внутриутробной задержки роста плода. Научные ведомости Белгородского государственного университета. Серия: Медицина. Фармация. 2012; 18(10): 132-6. [Zarudskaya O.M., Churnosov M.I. The role of hereditary thrombophilia in the development of chronic feto-placental insufficiency syndrome and intrauterine growth retardation of the fetus. Scientific statements BSU. Series: Medicine. Pharmacy. 2012; 18(10): 132-6. (in Russian)]
7. Кулаков В.И., Серов В.Н. ред. Рациональная фармакотерапия в акушерстве и гинекологии. Монография. М.: Литтерра; 2013. 720с. [Kulakov V.I., Serov V.N., ed. Rational pharmacotherapy in obstetrics and gynecology: Monograph. Moscow: Litterra; 2013. 720p. (in Russian)]
8. Стрижаков А.Н., Игнатко И.В., Тимохина Е.В., Белоцерковцева Л.Д. Синдром задержки роста плода. Патогенез. Диагностика. Лечение. Акушерская тактика. М.: ГЭОТАР-Медиа; 2013. 120с. [Strizhakov A.N., Ignatko I.V., Timokhina E.V., Belotserkovtseva L.D. Fetal growth retardation: Pathogenesis. Diagnostics. Treatment. Obstetric tactics. Moscow: GEOTAR-Media; 2013. 120p. (in Russian)]
9. Медведев М.В. Основы допплерографии в акушерстве. Практическое пособие для врачей. 4-е изд. М.: Реал Тайм; 2015. 80с. [Medvedev M.V. Basics Doppler ultrasound in obstetrics. A practical guide for physicians. 4th edition. Moscow: Real Time; 2015. 80p. (in Russian)]
10. Magdoud K., Herbepin V.G., Touraine R., Almawi W.Y., Mahjoub T. Plasminogen activator inhibitor 1 4G/5G and -844G/A variants in idiopathic recurrent pregnancy loss. Am. J. Reprod. Immunol. 2013; 70(3): 246-52.
11. D’Elia A.V., Fabbro D., Driul L. Plasminogen activator inhibitor-1 gene polymorphisms in pre-eclampsia. Semin. Thromb. Hemost. 2011; 37(2): 97-105.
12. Bates S.M. Preventing thrombophilia-related complications of pregnancy: an update. Expert Rev. Hematol. 2013; 6(3): 287-300.
13. Hossain N., Paidas M.J. Inherited thrombophilia: diagnosis and anticoagulation treatment in pregnancy. Clin. Lab. Med. 2013; 33(2): 377-90.
14. Said J.M., Higgins J.R., Moses E.K., Walker S.P., Borg A.J., Monagle P.T., Brennecke S.P. Inherited thrombophilia polymorphisms and pregnancy outcomes in nulliparous women. Obstet. Gynecol. 2010; 115(1):5-13.
15. Townsley D.M. Hematologic complications of pregnancy. Semin. Hematol. 2013; 50(3): 222-31.
16. Пизова Н.В. Тромбофилии: генетические полиморфизмы и сосудистые катастрофы. М.: ИМА-ПРЕСС; 2013. 248с. [Pizova N.V. Thrombophilia: genetic polymorphisms, and cardiovascular accident. Moscow: IMA-Press; 2013. 248p. (in Russian)]
17. Karimi M., Bereczky Z., Cohan N., Muszbek L. Factor XIII deficiency. Semin. Thromb. Hemost. 2009; 35(4): 426-38.
18. Huq F.Y., Kadir R.A. Management of pregnancy, labour and delivery in women with inherited bleeding disorders. Haemophilia. 2011; 17(Suppl. 1): 20-30.
19. Черкасский А.В., Башмакова Н.В., Третьякова Т.Б. Взаимосвязь коагуляционного потенциала крови, мутации гена, кодирующего А-субъединицу XIII фактора свертывания (F13A1), и тяжести послеоперационного спаечного процесса органов малого таза. Практическая медицина. 2012; 9: 77-9. [Cherkassky A.V., Bashmakova N.V., Tretyakov T.B. The relationship of blood coagulation potential gene mutations encoding A-subunit of coagulation factor XIII (F13A1), and severity of postoperative adhesions pelvic process. Prakticheskaya meditsina. 2012. 9: 77-9. (in Russian)]
20. Hogeveen M., Blom H. J., den Heijer M. Maternal homocysteine and small-for-gestational-age offspring: systematic review and meta-analysis. Am. J. Clin. Nutr. 2012: 95 (1): 130-6.
Received 15.12.2016
Accepted 23.12.2016
About the Authors
Nesterova Elvira Agzamovna, intramural post-graduate student, Ural Research Institute of Maternal and Infant Care, Ministry of Health of Russia.620028, Russia, Ekaterinburg, Repina str. 1. E-mail: elvira.nesterova.85@mail.ru
Putilova Natalia Viktorovna, MD, Head of the Department of antenatal protection of the fetus, Ural Research Institute of Maternal and Infant Care,
Ministry of Health of Russia. 620028, Russia, Ekaterinburg, Repina str. 1. Tel.: +73433715240. E-mail: putilova-1959@mail.ru
Tretyakova Tatyana Borisovna, PhD, a senior researcher at the Department of biochemical methods of investigation, Ural Research Institute of Maternal and Infant Care, Ministry of Health of Russia. 620028, Russia, Ekaterinburg, Repina str. 1. Tel.: +73433598190. E-mail: 79122467716@ya.ru
Pestryaeva Lyudmila Anatolevna, PhD, head of research department of biochemical methods of investigation, Ural Research Institute of Maternal and Infant Care,
Ministry of Health of Russia. 620028, Russia, Ekaterinburg, Repina str. 1. Tel.: +73433598190. E-mail: pestryaeval@yandex.ru
For citations: Nesterova E.A., Putilova N.V., Tretyakova T.B., Pestryaeva L.A. Role of genetically determined fetal hemostatic disorders in the development of severe forms of placental insufficiency. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2017; (9): 58-62. (in Russian)
http://dx.doi.org/10.18565/aig.2017.9.58-62